Research Directory

Development timelines for new oncology drugs

Read more

Swiss companies weather the turmoil in 2022

Read more

Capturing the promise of p38 MAPK inhibition

Read more

Destiny Pharma advances strategy against bacteria

Read more

HIV vaccine remains elusive but antivirals deliver value

Read more

FDA guides on accelerated approvals in oncology

Read more

Stock values decline and companies restructure

Read more

Adrenomed prepares global study in septic shock

Read more

Oncology pipeline marked by multiple therapy types

Read more

Targeting skeletal muscle to treat type 2 diabetes

Read more